Conference Material
|Slide Presentation

24-week regimens for treatment of rifampicin-resistant tuberculosis: four-arm randomised trial

Berry C, Motta I, Kazounis E, Fielding K, Dodd M, Nyang'wa BT, Moodliar R
Download
No abstract available

Countries

Belarus South Africa Uzbekistan

Subject Area

antibiotic resistancetuberculosisantimicrobial resistance

Languages

English
DOI
10.57740/v9ye-0032
Published Date
11 May 2022
Conference
MSF Scientific Days International 2022